At the 6th month, severe CFS/ME patients also demonstrated significant alterations in iNKT cell phenotypes, CD8+ T cell markers, NK cell receptors and γδ T cells compared with the control and/or moderate CFS/ME patients. This evidence concerns the gene KLRD1 and myalgic encephalomeyelitis/chronic fatigue syndrome.